Anthracyclines are active clinical agents that have multiple mechanisms of cytotoxicity. Cardiotoxicity by anthracyclines limits the therapeutic potential of these agents, but mechanisms leading to cardiotoxicity remain controversial. Transgenic mice that lack mitochondrial topoisomerase I are hypersensitive to doxorubicin cardiotoxicity, providing support for cardiotoxicity arising from damage of mitochondrial DNA.
CITATION STYLE
Nitiss, K. C., & Nitiss, J. L. (2014). Twisting and ironing: Doxorubicin cardiotoxicity by mitochondrial DNA damage. Clinical Cancer Research, 20(18), 4737–4739. https://doi.org/10.1158/1078-0432.CCR-14-0821
Mendeley helps you to discover research relevant for your work.